Cargando…

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study

INTRODUCTION: The c.1-34T>C 5' promoter region polymorphism in cytochrome P450c17 (CYP17), a key enzyme in the biosynthesis of estrogen, has been associated with breast cancer risk, but most previous studies have been relatively small. METHODS: We genotyped 1,544 incident cases of primary br...

Descripción completa

Detalles Bibliográficos
Autores principales:	Einarsdóttir, Kristjana, Rylander-Rudqvist, Tove, Humphreys, Keith, Ahlberg, Susanne, Jonasdottir, Gudrun, Weiderpass, Elisabete, Chia, Kee Seng, Ingelman-Sundberg, Magnus, Persson, Ingemar, Liu, Jianjun, Hall, Per, Wedrén, Sara
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410739/ https://www.ncbi.nlm.nih.gov/pubmed/16280037 http://dx.doi.org/10.1186/bcr1319

Ejemplares similares

Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study
por: Rosenberg, Lena U, et al.
Publicado: (2008)

Linkage Disequilibrium Mapping of CHEK2: Common Variation and Breast Cancer Risk
por: Einarsdóttir, Kristjana, et al.
Publicado: (2006)

Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study
por: Einarsdóttir, Kristjana, et al.
Publicado: (2006)

The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects
por: Sim, Sarah C, et al.
Publicado: (2010)

Liquid Biopsies or Therapeutic Drug Monitoring for CYP Activity Profile Determination
por: Pridgeon, Chris S., et al.
Publicado: (2022)

The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals
por: Haeggström, Sigrid, et al.
Publicado: (2022)

CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload
por: Harjumäki, Riina, et al.
Publicado: (2021)

ESR1 and EGF genetic variation in relation to breast cancer risk and survival
por: Einarsdóttir, Kristjana, et al.
Publicado: (2008)

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
por: Li, Yuqing, et al.
Publicado: (2011)

Oestrogen receptor α gene haplotype and postmenopausal breast cancer risk: a case control study
por: Wedrén, Sara, et al.
Publicado: (2004)

Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population
por: Bråten, Line Skute, et al.
Publicado: (2022)

Estrogen receptor alpha gene polymorphism and endometrial cancer risk – a case-control study
por: Wedrén, Sara, et al.
Publicado: (2008)

Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene
por: Persson, A, et al.
Publicado: (2014)

Analysis of binary traits: testing association in the presence of linkage
por: Jonasdottir, Gudrun, et al.
Publicado: (2005)

The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database
por: Gaedigk, Andrea, et al.
Publicado: (2017)

The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients
por: Lenk, Hasan Çağın, et al.
Publicado: (2022)

Intronic polymorphisms of cytochromes P450
por: Ingelman-Sundberg, Magnus, et al.
Publicado: (2010)

The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity
por: Lauschke, Volker M., et al.
Publicado: (2016)

Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementation
por: Lauschke, Volker M., et al.
Publicado: (2020)

Developmental Regulation and Induction of Cytochrome P450 2W1, an Enzyme Expressed in Colon Tumors
por: Choong, Eva, et al.
Publicado: (2015)

Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits
por: Lenk, Hasan Çağın, et al.
Publicado: (2022)

Excess body weight, weight gain and obesity-related cancer risk in women in Norway: the Norwegian Women and Cancer study
por: da Silva, Marisa, et al.
Publicado: (2018)

Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity
por: Lauschke, Volker M., et al.
Publicado: (2019)

Use of skincare products and risk of cancer of the breast and endometrium: a prospective cohort study
por: Rylander, Charlotta, et al.
Publicado: (2019)

Preventable fractions of cancer incidence attributable to 7-years weight gain in the Norwegian Women and Cancer (NOWAC) study
por: da Silva, Marisa, et al.
Publicado: (2021)

Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profiling
por: Ingelman-Sundberg, Magnus, et al.
Publicado: (2023)

Integrating rare genetic variants into pharmacogenetic drug response predictions
por: Ingelman-Sundberg, Magnus, et al.
Publicado: (2018)

Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements
por: Shekhani, Rawan, et al.
Publicado: (2019)

Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968 – 2002
por: Sim, Xueling, et al.
Publicado: (2006)

The burden of colon cancer attributable to modifiable factors—The Norwegian Women and Cancer Study
por: Lukic, Marko, et al.
Publicado: (2022)

Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions
por: Vorrink, Sabine U, et al.
Publicado: (2018)

The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids
por: Trampuž, Sara Redenšek, et al.
Publicado: (2023)

Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women
por: Suzuki, R, et al.
Publicado: (2008)

The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia
por: Milosavljević, Filip, et al.
Publicado: (2023)

Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival
por: Einarsdóttir, K, et al.
Publicado: (2009)

A 3D Cell Culture Model Identifies Wnt/β‐Catenin Mediated Inhibition of p53 as a Critical Step during Human Hepatocyte Regeneration
por: Oliva‐Vilarnau, Nuria, et al.
Publicado: (2020)

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
por: van Westrhenen, Roos, et al.
Publicado: (2020)

Association of Gestational Age at Birth with Reasons for Subsequent Hospitalisation: 18 Years of Follow-Up in a Western Australian Population Study
por: Srinivasjois, Ravisha, et al.
Publicado: (2015)

In-solution hybrid capture of bisulfite-converted DNA for targeted bisulfite sequencing of 174 ADME genes
por: Ivanov, Maxim, et al.
Publicado: (2013)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
por: van Schaik, Ron H. N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jgvhpmj1abfiri67l23jujs42b